IRIS
MOTTA, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.439
AS - Asia 2.888
EU - Europa 2.522
Continente sconosciuto - Info sul continente non disponibili 405
SA - Sud America 371
AF - Africa 44
OC - Oceania 4
Totale 27.673
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.259
SG - Singapore 1.383
IT - Italia 670
CN - Cina 507
BR - Brasile 309
DE - Germania 274
UA - Ucraina 263
RU - Federazione Russa 258
HK - Hong Kong 218
KR - Corea 217
VN - Vietnam 203
IE - Irlanda 186
GB - Regno Unito 169
FR - Francia 159
SE - Svezia 153
BD - Bangladesh 120
PL - Polonia 104
CA - Canada 92
FI - Finlandia 89
NL - Olanda 83
JP - Giappone 70
IN - India 43
AR - Argentina 29
AT - Austria 23
ZA - Sudafrica 19
ES - Italia 18
TR - Turchia 17
CR - Costa Rica 16
BE - Belgio 14
CZ - Repubblica Ceca 14
UZ - Uzbekistan 14
EU - Europa 13
ID - Indonesia 13
IQ - Iraq 13
MX - Messico 13
TT - Trinidad e Tobago 12
EC - Ecuador 10
JM - Giamaica 10
HN - Honduras 9
SA - Arabia Saudita 9
SV - El Salvador 8
KE - Kenya 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
DK - Danimarca 6
GT - Guatemala 6
IL - Israele 6
LT - Lituania 6
PK - Pakistan 6
CW - ???statistics.table.value.countryCode.CW??? 5
PH - Filippine 5
RO - Romania 5
TN - Tunisia 5
AU - Australia 4
EE - Estonia 4
EG - Egitto 4
NP - Nepal 4
PY - Paraguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
CL - Cile 3
IR - Iran 3
KZ - Kazakistan 3
MY - Malesia 3
NO - Norvegia 3
PR - Porto Rico 3
RS - Serbia 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
VE - Venezuela 3
AL - Albania 2
BN - Brunei Darussalam 2
CH - Svizzera 2
DM - Dominica 2
DZ - Algeria 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NI - Nicaragua 2
OM - Oman 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
KH - Cambogia 1
MA - Marocco 1
Totale 27.276
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.497
Wilmington 5.202
Houston 4.503
Fairfield 628
Singapore 613
Ashburn 597
Ann Arbor 410
San Jose 402
Chandler 348
Seattle 239
Hong Kong 214
Council Bluffs 210
Beijing 209
Jacksonville 208
Rome 208
Cambridge 189
Dublin 177
Medford 137
Santa Clara 115
New York 114
Dearborn 104
Los Angeles 90
The Dalles 81
Kraków 78
Ho Chi Minh City 65
Lawrence 65
Tokyo 57
Buffalo 52
Hanoi 52
Lauterbourg 48
Milan 47
San Diego 47
Dallas 45
Munich 44
Zhengzhou 44
Moscow 41
Chicago 36
Manchester 32
São Paulo 32
Helsinki 31
North Bergen 29
Norwalk 29
Denver 25
London 24
Maastricht 23
Brooklyn 20
Atlanta 19
Menlo Park 19
Naples 19
Palo Alto 19
Warsaw 19
Montreal 17
Mülheim 17
Orem 17
Chennai 16
Düsseldorf 16
Johannesburg 16
Hangzhou 15
Redondo Beach 15
Redwood City 15
Toronto 15
Vienna 15
Salt Lake City 14
Brno 13
Brussels 13
Carrboro 13
San José 13
Verona 13
Amsterdam 12
Belo Horizonte 12
Boardman 12
Hefei 12
Mountain View 12
Philadelphia 12
Phoenix 12
Seoul 12
Monte Vista 11
Nanjing 11
San Francisco 11
Tashkent 11
University Park 11
Da Nang 10
Frankfurt am Main 10
Madrid 10
Nuremberg 10
Rio de Janeiro 10
Washington 10
Pieve a Nievole 9
Poplar 9
Bologna 8
Guangzhou 8
Kunming 8
Mumbai 8
Stockholm 8
Turku 8
Calgary 7
Chaguanas 7
Columbus 7
Eijsden 7
Elk Grove Village 7
Totale 22.121
Salva come PNG Salva come JPEG
Nome #
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 617
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 590
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 532
Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease 531
Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes 515
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 509
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 498
Subclinical central inflammation is risk for RIS and CIS conversion to MS 493
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis 492
Gabaergic and glutamatergic synaptic transmissions are altered after cuprizone exposure: implication for schizophrenia and demyelinating diseases 492
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis 483
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 481
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 480
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 480
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 474
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment 472
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 465
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 463
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis 461
Disability and its progression can be objectively measured in multiple sclerosis 452
Inflammation inhibits GABA transmission in multiple sclerosis 451
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation 451
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 450
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 449
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System 448
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission 448
Endovascular Stroke Treatment of Acute Tandem Occlusion: A Single-Center Experience 440
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 437
The autonomic balance predicts cardiac responses after the first dose of fingolimod 437
Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis 432
Neural stem cell transplantation promotes post-ischemic neuronal plasticity by regulating the expression of glutamate transporters 432
Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis 430
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis 427
Efficacy and Safety of Mechanical Thrombectomy in Older Adults with Acute Ischemic Stoke 426
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis 425
CT angiography-based collateral flow and time to reperfusion are strong predictors of outcome in endovascular treatment of patients with stroke 425
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis 420
Plasmacytoid dendritic cells induce an immunoregulatory T helper 9 profile in multiple sclerosis 417
Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids 413
Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis 411
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis 410
Effect of Glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab 406
Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis 406
Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum 403
TNF-α-mediated anxiety in a mouse model of multiple sclerosis 400
CT angiography ASPECTS predicts outcome much better than noncontrast CT in patients with stroke treated endovascularly 393
Pretreatment predictors of malignant evolution in patients with ischemic stroke undergoing mechanical thrombectomy 391
Proposed chronic cerebrospinal venous insufficienty criteria do not predict multiple sclerosis risk or severity 387
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis 385
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease 380
Long-term potentiation-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset 363
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 330
Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial 291
Effects of palmitoylethanolamide combined with luteoline on frontal lobe functions, high frequency oscillations, and GABAergic transmission in patients with frontotemporal dementia 290
Heparin during endovascular stroke treatment seems safe 217
LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients. 214
Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial 207
Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study 206
LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment 199
Protective role of cerebrospinal fluid inflammatory cytokines in patients with amnestic mild cognitive impairment and early Alzheimer's disease carrying apolipoprotein E4 genotype 186
Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer’s disease 178
Clinical and histological study of a xenogenic bone substitute used as a filler in postextractive alveolus 165
Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia 138
Autonomic Dysfunction in Patients With Dementia With Lewy Bodies and Its Relationship With Nigrostriatal Denervation 136
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias 135
Diabetes Mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with APOE4 genotype 126
Blood–brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease 122
Decreased Frontal Gamma Activity in Alzheimer Disease Patients 122
Isolated amyloid-β pathology is associated with preserved cortical plasticity in APOE4 Alzheimer's disease patients 119
Effects of 52 weeks of precuneus rTMS in Alzheimer's disease patients: a randomized trial 108
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study 105
Functional correlates of microglial and astrocytic activity in symptomatic sporadic Alzheimer's disease: a CSF/18F-FDG-PET study 94
Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patients 86
Improving visuo-motor learning with cerebellar theta burst stimulation: behavioral and neurophysiological evidence 78
Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer's Disease 74
Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neuroinflammation processes in the Alzheimer's disease continuum 69
Biobanking for Neurodegenerative Diseases: Challenge for Translational Research and Data Privacy 68
Intermittent cerebellar theta burst stimulation improves visuo-motor learning in stroke patients: a pilot study 64
Rethinking dementia in the oldest old: Lessons to learn for the diagnosis and treatment of Alzheimer’s disease 60
Opposing patterns of blood-brain barrier permeability and Alzheimer’s disease biomarkers across APOE genotype 58
Reframing TDP‐43 in Alzheimer's disease: From co‐pathology to neurovascular culprit 53
Beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies 53
Elevated plasma p-tau217 in newborns: developmental signal or synaptic stress marker? 45
Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum. 45
Reply to: letter to the editor regarding “beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies” 43
Chronic fasudil treatment induces benzodiazepine-like tolerance via modulation of GABA-A receptor γ2 subunit expression and impairs contextual fear memory in mice 43
An Out-of-Place Etiology: Recognizing FMR1 Premutation in the Memory Clinic 38
NOTCH3 variants of unknown significance underpin vascular dysfunction in neurodegenerative disease: a case series of three nfvPPA-FTD patients 36
Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trial 35
Lecanemab’s Path Forward: Navigating the Future of Alzheimer’s Treatment in Europe Amidst the EMA's Rejection 34
Streamlining Alzheimer's disease diagnosis: real-world validation of two-cut-off diagnostic models based on plasma p-tau/Aβ42 ratios 30
Totale 27.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022559 0 0 0 37 26 84 36 28 54 55 50 189
2022/2023850 119 90 20 103 73 187 62 49 63 12 53 19
2023/2024254 37 7 22 12 22 70 12 4 3 5 8 52
2024/20252.154 66 374 179 113 74 256 112 89 149 176 321 245
2025/20263.514 249 161 373 262 312 124 460 357 457 281 275 203
2026/20271.494 189 218 618 469 0 0 0 0 0 0 0 0
Totale 27.673